Traphagen, N. A., Wheeler, E., Li, R., Akhshi, T., Ravindranathan, R., Alfieri, C., Lu, F., Ahmed, B., Tewari, A. K., Balk, S. P., Nelson, P. S., Corey, E., Long, H., D’Andrea, A. D., Qiu, X., Brown, M. (2026). Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination–proficient prostate cancer. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2515790122